---
schema_version: "secwatch.filing_event.v1"
accession: "0000937556-23-000193"
form_type: "8-K"
ticker: "MASI"
cik: "0000937556"
company_name: "MASIMO CORP"
filed_at: "2023-08-08T23:59:59+00:00"
generated_at: "2026-06-12T03:32:46.117706+00:00"
event_type: "earnings"
sentiment: "negative"
materiality_score: 0.75
calibrated_materiality_score: 0.75
confidence: "high"
source: SEC EDGAR
---

# Masimo Q2 revenue $455M, EPS $0.29 GAAP; cuts FY guidance to $2.1-2.2B

## Summary
- Consolidated revenue $455.3M (healthcare $281.1M, non-healthcare $174.2M); GAAP EPS $0.29, non-GAAP $0.62.
- GAAP operating income $29.3M, non-GAAP $58.6M; 64,100 noninvasive tech board shipments.
- CEO disappointed; record hospital customer gains but inpatient volumes below expectations.
- Updated Q3 2023 revenue guidance $475-525M; full-year revenue $2.1-2.2B (down from prior).
- Full-year GAAP EPS guidance $1.91-2.11; non-GAAP $3.35-3.55.

## SEC filing metadata
- accession: 0000937556-23-000193
- form_type: 8-K
- ticker: MASI
- cik: 0000937556
- company_name: MASIMO CORP
- filed_at: 2023-08-08T23:59:59+00:00
- event_type: earnings
- sentiment: negative
- materiality_score: 0.75
- calibrated_materiality_score: 0.75
- confidence: high
- sec_items: 2.02, 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/937556/000093755623000193/0000937556-23-000193-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/937556/000093755623000193/masi-20230808.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0000937556-23-000193
- JSON: https://secwatch.observer/filing/0000937556-23-000193.json
- Plain text: https://secwatch.observer/filing/0000937556-23-000193.txt

## Key facts
- Earnings Releases
  MASIMO CORP reported second quarter of 2023, ended July 1, 2023 results: revenue $455.3 million, net income $15.7 million, or $0.29 per diluted share, EPS $0.29 per diluted share.
  - Period: second quarter of 2023, ended July 1, 2023
  - Revenue: $455.3 million
  - Net income: $15.7 million, or $0.29 per diluted share
  - EPS: $0.29 per diluted share
  - Result: reported results
  source text: by specific reference in such filing. --- EX-99.1 (EX-99.1) --- Masimo Reports Second Quarter 2023 Financial Results Second Quarter 2023 Highlights • Consolidated revenue was $455.3 million; • Healthcare revenue was $281.1 million; • Non-healthcare revenue was $174.2 million; • GAAP net income per diluted share was $0.29; and • Non-GAAP net income per diluted share
  evidence_url: https://www.sec.gov/Archives/edgar/data/937556/000093755623000193/0000937556-23-000193-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.